Quantcast
Last updated on April 16, 2014 at 4:43 EDT

Latest Molecular imaging Stories

2012-08-16 06:24:59

CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company is pleased to announce the use of their Attrius system at Caring Heart and Brain Imaging Inc., of Manasquan, New Jersey, which now offers Amyvid PET scans to identify the presence of plaque in the brain, which has been shown to be a precursor to Alzheimer's disease. Amyvid(TM) (Florbetapir F-18 Injection) is indicated for Positron Emission Tomography (PET) imaging of the...

2012-08-07 02:29:31

LOS ANGELES and SINGAPORE, Aug. 7, 2012 /PRNewswire/ -- ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that it has signed a Master Service Agreement (MSA) with Singapore Radiopharmaceuticals Pte Ltd, a subsidiary of Fortis HealthCare. "This agreement represents an important component of our expansion program in Singapore as we establish R&D and pre-clinical imaging capabilities there," said Christian...

2012-08-06 02:25:59

DULLES, Va. and MUMBAI, India, Aug. 6, 2012 /PRNewswire/ -- IBA Molecular and Piramal Imaging SA (Piramal) have announced an agreement whereby IBA Molecular will manufacture and distribute 18F-Florbetaben, Piramal's new diagnostic imaging agent, in the European and US markets. 18F- Florbetaben is a radiopharmaceutical currently in development for use with positron emission tomography (PET) for the detection of beta-Amyloid plaque deposition in the brain, a pathological feature associated with...

2012-08-03 14:22:41

BETHESDA, Md., Aug. 3, 2012 /PRNewswire-USNewswire/ -- The American Society of Nuclear Cardiology (www.asnc.org) will host its annual meeting, ASNC2012 -- The 17th Annual Scientific Session, September 6 - 9, 2012 in Baltimore. Close to a thousand imaging specialists from around the world will gather at ASNC2012 to attend sessions focused on nuclear cardiology's place in the imaging landscape, including joint sessions to bring a multi-modality approach to conversations about cardiovascular...

2012-07-20 06:22:25

GARY, Ind., July 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, announces approval of a Pledge Resolution for $15 Million in Tax Increment Financing (TIF) Bonds, from the Redevelopment Commission of the City of Gary, Indiana towards the development of Positron's 70 MeV cyclotron project. In addition to the TIF incentives, the City of Gary will assist in sourcing the appropriate allocation of New Market Tax Credits (NMTC) that could...

2012-07-11 02:26:18

CULVER CITY, Calif., July 11, 2012 /PRNewswire/ -- Sofie Biosciences, Inc., a molecular imaging company offering a comprehensive range of products from preclinical imaging systems to novel diagnostic PET imaging probes, announced today that the Department of Energy has awarded the company a grant under the Small Business Innovation Research (SBIR) program. This Phase II award, for approximately $1M, will support the development of a microscale technology for rapid, easy synthesis of PET...

2012-07-02 06:24:39

BIRMINGHAM, Ala. and SHREVEPORT, La., July 2, 2012 /PRNewswire-USNewswire/ -- Using preclinical molecular imaging, scientists from Southern Research Institute and LSU Health Sciences Center in Shreveport have published data which could lead to better diagnosis and treatment of Parkinson's disease. Their study--"PET Imaging a MPTP-Induced Mouse Model of Parkinson's Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [18F]-DTBZ (AV-133)"--was published in a recent edition (June 18,...

2012-06-12 02:26:02

MOUNTAIN VIEW, Calif., June 12, 2012 /PRNewswire/ -- Current optical imaging technologies provide reproducible, accurate, objective, quantitative assessments of tissue structures. As the marked progress in optical imaging techniques observed in recent years is instigating a new wave of business opportunities, there are still areas to improve. Analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Emerging Trends in Optical Imaging Techniques for Drug Discovery,...

2012-06-11 21:35:48

Studies show a naturally occurring protein called beta amyloid may be the key to diagnosis and could even be the answer to treating the neurodegenerative disease An arsenal of Alzheimer's research revealed at the Society of Nuclear Medicine's 59th Annual Meeting indicates that beta-amyloid plaque in the brain not only is involved in the pathology of Alzheimer's disease but may also precede even mild cognitive decline. These and other studies advance molecular imaging for the early...

2012-06-11 21:24:03

Study finds that a combination of molecular imaging, radiography and dual imaging probes detects more cancerous bone lesions than other methods Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting describes new approaches to imaging for the detection of tumors in complex cases of bone cancer. Hybrid imaging technology combining computed tomography (CT) with molecular imaging agents targeting two different markers of disease came out on top of the list for the...